|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 23, 2017 ) The North America Blood Testing Market was worth $18.48 billion in 2016 and estimated to be growing at a CAGR of 2.32%, to reach $20.73 billion by 2021. Rising government initiatives and increase in the number of surgical procedures in North America are the factors propelling the demand for blood tests in this region.
Demand for blood is endlessly increasing with patients undergoing complex surgeries that involve blood transfusions. For the support of patients, countries are growing their healthcare treatment so that maximum number of people can benefit out of required treatment.
View Full Report @ http://www.marketdataforecast.com/market-reports/north-america-blood-testing-market-1406/
Increasing concerns about spread of infectious diseases through donated blood has augmented the demand for blood and blood products. With the boost in geriatric population and incidence of diseases, there is a raise in the blood testing in the developed regions such as North America. The cost of blood handling equipment is a key challenge faced by the blood testing market.
The North America blood testing market Size is segmented on the basis of type into Complete Blood Count, Blood Chemistry Tests, Blood Enzymes Tests and Blood Clotting Tests. Complete Blood Count segmented is further divided into Red Blood Cells, White Blood Cells, Haemoglobin, Hematocrit and Platelets. Blood Chemistry Tests are bifurcated among Test for Electrolytes, Blood Glucose, Calcium and Test for Kidney Function. Blood Enzymes Tests are sub segmented into Troponin and Creatine Kinase.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/north-america-blood-testing-market-1406/request-sample
Blood Clotting Tests Segment is segregated among Prothrombin time and Activated Partial Thromboplastin time and Blood Coagulation. On the basis of diseases the market is divided into Anaemia, Infection, Leukaemia, Hypokalemia, Kidney Disorders, Heart Attack and Coronary Heart Disease. Based on Methods, market is bifurcated among Manual Blood Culture Testing and Automated Blood Culture Testing. Automated Blood Culture Testing division is further sub segmented into Automated Blood Culture System and Blood Culture Instruments.
Inquire before Buying @ http://www.marketdataforecast.com/market-reports/north-america-blood-testing-market-1406/inquire
Based on geography the North America market is analysed under various countries namely, USA and Canada. USA is leading the region’s market in terms of revenue followed by Canada.
Major players in this market are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
